New York State Common Retirement Fund
PHAS

New York State Common Retirement Fund’s PhaseBio Pharmaceuticals, Inc. Common Stock PHAS Stock Holding History

New York State Common Retirement Fund’s Portfolio PHAS Stock Details PHAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-106
Closed – – 3605
2021
Q2 		$0 Sell
106
-13,994
-99% -$46.6K ﹤0.01% 3593
2021
Q1 		$49K Hold
14,100
– – ﹤0.01% 3225
2020
Q4 		$47K Hold
14,100
– – ﹤0.01% 3196
2020
Q3 		$49K Hold
14,100
– – ﹤0.01% 3143
2020
Q2 		$65K Hold
14,100
– – ﹤0.01% 3121
2020
Q1 		$47K Hold
14,100
– – ﹤0.01% 2995
2019
Q4 		$86K Hold
14,100
– – ﹤0.01% 3039
2019
Q3 		$59K Hold
14,100
– – ﹤0.01% 3146
2019
Q2 		$185K Buy
+14,100
New +$173K ﹤0.01% 2859

Other funds holding PHAS

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return
ACM
Altium Capital Management New York $42M AUM

New York State Common Retirement Fund's PHAS Position: Q3 2021 in Review

New York State Common Retirement Fund sold out of PhaseBio Pharmaceuticals, Inc. Common Stock (PHAS) in Q3 2021, closing a stake of 106 shares.

New York State Common Retirement Fund first reported a position in PHAS in Q2 2019 and held it in 9 quarters. The position peaked at $185K in Q2 2019. 61 funds tracked by Wall St. Rank hold PHAS as of Q3 2021.

  • New York State Common Retirement Fund reported no remaining PhaseBio Pharmaceuticals, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • New York State Common Retirement Fund sold 106 PhaseBio Pharmaceuticals, Inc. Common Stock shares in Q3 2021.
  • New York State Common Retirement Fund first reported a position in PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2019 and held it in 9 quarters.
  • New York State Common Retirement Fund's PhaseBio Pharmaceuticals, Inc. Common Stock position peaked at $185K in Q2 2019.
  • 61 funds tracked by Wall St. Rank held PhaseBio Pharmaceuticals, Inc. Common Stock as of Q3 2021.

Based on New York State Common Retirement Fund's 13F filing for Q3 2021, filed 2 Nov 2021.